How to treat Lung cancer?

Jinsi ya kutibu kansa ya mapafu?

Matibabu ya kansa ya mapafu hutegemea mambo kadhaa, kutia ndani hatua ya kansa, aina ya kansa ya mapafu, na afya ya mgonjwa kwa ujumla.

Baadhi ya njia za kawaida za kutibu ni pamoja na:

1. Upasuaji: Mara nyingi huu ndio tiba inayopendekezwa kwa kansa ya mapafu iliyo katika hatua ya mapema.

Daktari-mpasuaji huondoa uvimbe huo na sehemu ndogo ya tishu nzuri inayouzunguka.

2. Tiba ya mionzi: Mionzi yenye nishati kubwa hutumiwa kuua chembe za kansa na kupunguza ukubwa wa uvimbe.

Inaweza kutumiwa peke yake au kuunganishwa na matibabu mengine.

3. Tiba ya kemikali: Tiba hii hutumia dawa kuua chembe za kansa.

Inaweza kutolewa kwa njia ya ndani ya mshipa au kwa mdomo, na mara nyingi hutumiwa pamoja na matibabu mengine.

4. Tiba inayolengwa: Tiba hii inalenga jeni au protini hususa zinazochangia ukuzi na uhai wa chembe za kansa.

Mara nyingi hutumiwa kwa saratani ya mapafu iliyoendelea au iliyoenea.

5. Tiba ya kinga: Tiba hii husaidia mfumo wa kinga kutambua na kushambulia chembe za kansa.

Mara nyingi hutumiwa kwa saratani ya mapafu iliyoendelea au iliyoenea.

6. Tiba ya Photodynamic: Tiba hii hutumia dawa inayotumiwa na nuru kuua chembe za kansa.

Mara nyingi hutumiwa kwa kansa ya mapafu katika hatua ya mapema.

7. Tiba ya protoni: Hii ni aina ya tiba ya mnururisho inayotumia protoni badala ya miale ya X ili kutoa mnururisho kwenye uvimbe.

Mara nyingi hutumiwa kwa kansa ya mapafu katika hatua ya mapema.

8. Majaribio ya kliniki: Wagonjwa wanaweza kuwa na haki ya kushiriki katika majaribio ya kliniki ya kupima matibabu mapya au mchanganyiko wa matibabu.

Ni muhimu kujadili chaguzi bora za matibabu na timu ya utunzaji wa afya, kwani mpango bora zaidi wa matibabu utategemea hali maalum ya mtu binafsi.

Marejeo

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Chen JH, Wu J, Xu Q: The emerging treatment landscape of targeted therapy in non-small-cell lung cancer. Signal Transduct Target Ther. , 4 (): 61.

Furuse K: [Photodynamic therapy of centrally located early-stage lung cancer]. Gan To Kagaku Ryoho. 1996, 23 (1): 27-30.

Gálffy G: [From rare mutations to classical ones, inhibition of signaling pathways in non-small cell lung cancer]. Magy Onkol. 2020, 64 (3): 196-204.

Magalhães M, Alvarez-Lorenzo C, Concheiro A, Figueiras A, Santos AC, Veiga F: RNAi-based therapeutics for lung cancer: biomarkers, microRNAs, and nanocarriers. Expert Opin Drug Deliv. 2018, 15 (10): 965-982.

Kataoka M, Fujiwara T, Tanaka N: [Gene therapy for lung cancer]. Nihon Geka Gakkai Zasshi. 2002, 103 (2): 244-9.

Jin C, Yang B: A Case of Delayed Diagnostic Pulmonary Tuberculosis during Targeted Therapy in an EGFR Mutant Non-Small Cell Lung Cancer Patient. Case Rep Oncol. , 14 (1): 659-663.

Wang Y, Liu Q, Chen H, You J, Peng B, Cao F, Zhang X, Chen Q, Uzan G, Xu L, Zhang D: Celastrol improves the therapeutic efficacy of EGFR-TKIs for non-small-cell lung cancer by overcoming EGFR T790M drug resistance. Anticancer Drugs. 2018, 29 (8): 748-755.

Kanusho la dhima: matibabu

Tovuti hii hutolewa kwa madhumuni ya elimu na habari tu na si kutoa ushauri wa matibabu au huduma za kitaaluma.

Habari inayotolewa haipaswi kutumiwa kugundua au kutibu tatizo la afya au ugonjwa, na wale wanaotafuta ushauri wa kibinafsi wa kitiba wanapaswa kushauriana na daktari aliye na leseni.

Tafadhali kumbuka mtandao wa neva ambao hutengeneza majibu ya maswali, ni hasa usio sahihi linapokuja maudhui ya nambari. Kwa mfano, idadi ya watu waliogunduliwa na ugonjwa fulani.

Daima kutafuta ushauri wa daktari wako au mtoa huduma nyingine ya afya waliohitimu kuhusu hali ya matibabu. Kamwe kupuuza ushauri wa matibabu ya kitaaluma au kuchelewesha katika kutafuta yake kwa sababu ya kitu umesoma kwenye tovuti hii. Kama unafikiri unaweza kuwa na dharura ya matibabu, piga simu 911 au kwenda chumba cha dharura karibu mara moja. Hakuna uhusiano daktari-mgonjwa ni kuundwa na tovuti hii au matumizi yake. Wala BioMedLib wala wafanyakazi wake, wala mchangiaji yoyote ya tovuti hii, hufanya uwakilishi wowote, wazi au implicit, kuhusiana na taarifa zinazotolewa hapa au matumizi yake.

Utoaji wa dhima: hakimiliki

The Digital Millennium Copyright Act ya 1998, 17 U.S.C. § 512 (the DMCA) hutoa njia ya kurudi kwa wamiliki wa hakimiliki ambao wanaamini kuwa vifaa vinavyoonekana kwenye Mtandao vinakiuka haki zao chini ya sheria ya hakimiliki ya Merika.

Kama unaamini kwa imani nzuri kwamba maudhui yoyote au nyenzo zilizotolewa kuhusiana na tovuti yetu au huduma inakiuka hakimiliki yako, wewe (au wakala wako) unaweza kutuma sisi taarifa kuomba kwamba maudhui au nyenzo kuondolewa, au upatikanaji wake kuzuiwa.

Taarifa lazima zipelekwe kwa maandishi kwa barua pepe (tazama sehemu ya "Contact" kwa anwani ya barua pepe).

DMCA inahitaji kwamba taarifa yako ya madai ya ukiukaji wa hakimiliki ni pamoja na taarifa zifuatazo: (1) maelezo ya kazi ya hakimiliki ambayo ni madai ya ukiukaji; (2) maelezo ya madai ya ukiukaji maudhui na habari ya kutosha kuruhusu sisi kupata maudhui; (3) mawasiliano ya habari kwa ajili yenu, ikiwa ni pamoja na anwani yako, nambari ya simu na anwani ya barua pepe; (4) taarifa na wewe kuwa na imani nzuri imani kwamba maudhui katika njia alilalamika ya si mamlaka na mmiliki wa hakimiliki, au wakala wake, au na operesheni ya sheria yoyote;

(5) taarifa na wewe, saini chini ya adhabu ya ushahidi wa uongo, kwamba habari katika taarifa ni sahihi na kwamba una mamlaka ya kutekeleza haki za hakimiliki ambayo ni madai ya kukiuka;

na (6) saini ya kimwili au ya elektroniki ya mmiliki wa hakimiliki au mtu aliyeidhinishwa kutenda kwa niaba ya mmiliki wa hakimiliki.

Kushindwa kujumuisha habari zote hapo juu kunaweza kusababisha ucheleweshaji wa usindikaji wa malalamiko yako.

Mawasiliano

Tafadhali tutumie barua pepe na swali lolote / pendekezo.

How to treat lung cancer?

The treatment for lung cancer depends on several factors, including the stage of the cancer, the type of lung cancer, and the patient's overall health.

Some common treatment options include:

1. Surgery: This is often the preferred treatment for early-stage lung cancer.

The surgeon removes the tumor and a small portion of healthy tissue around it.

2. Radiation therapy: High-energy radiation is used to kill cancer cells and shrink tumors.

It can be used alone or in combination with other treatments.

3. Chemotherapy: This treatment uses drugs to kill cancer cells.

It can be given intravenously or or orally, and is often used in combination with other treatments.

4. Targeted therapy: This treatment targets specific genes or proteins that contribute to the growth and survival of cancer cells.

It is often used for advanced or metastatic lung cancer.

5. Immunotherapy: This treatment helps the immune system recognize and attack cancer cells.

It is often used for advanced or metastatic lung cancer.

6. Photodynamic therapy: This treatment uses a light-activated drug to kill cancer cells.

It is often used for early-stage lung cancer.

7. Proton therapy: This is a type of radiation therapy that uses protons instead of x-rays to deliver radiation to the tumor.

It is often used for early-stage lung cancer.

8. Clinical trials: Patients may be eligible to participate in clinical trials testing new treatments or combinations of treatments.

It is important to discuss the best treatment options with a healthcare team, as the most effective treatment plan will depend on the individual's specific situation.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.